stockrow
Monday 9 November 2026
Export ALMR’s income statement to Excel — free account
Alamar Biosciences, Inc.
ALMRAlamar Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $74.2 million, up 195.2% from fiscal 2024.
- Revenue
- +68.5%
- EPS
- +72.0%
- Free cash flow
- +1.07%
Quarter to September 2026, against a year earlier
28.05
1.14
+4.24%
Follow ALMR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (64.60%) | 0.00% | 0.00% | 0.00% |
+4 more TTM periods Free account |
|
| (20.85%) | (25.40%) | (25.89%) | 0.00% | ||
ROIC |
(38.90%) | (35.00%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(18.37%) | (15.68%) | (34.00%) | (36.60%) | |
Average Days of Receivables |
69.16 | 73.95 | 81.77 | 62.72 | |
Free Cash Flow per Share |
(0.99) | (1.17) | (5.41) | (5.11) | |
Free Cash Flow |
(68.47) | (68.63) | (66.31) | (58.98) | |
Capital Expenditures |
(7.55) | (8.31) | (5.42) | (5.37) | |
| Other line items | |||||
Cash ROIC |
(12.91%) | (11.98%) | 172.16% | 49.50% | |
Accounts Receivable Turnover |
8.07 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
4.08 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
1.35 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
130.19 | 121.26 | 55.02 | 65.93 | |
Days of Inventory on Hand |
425.88 | 399.28 | 389.89 | 432.10 | |
Tax Rate |
0.01 | 0.02 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
46.53% | 46.91% | 48.40% | 50.49% | |
Selling, General and Administrative Expense of Revenue |
54.87% | 52.32% | 49.01% | 47.93% | |
Share Based Compensation of Revenue |
8.21% | 6.11% | 3.98% | 0.00% | |
Interest Coverage |
(58.39) | (54.03) | (60.78) | (78.14) | |
Operating CF/Net income |
1.11 | 1.21 | 1.40 | 1.80 | |
Depreciation/Fixed assets |
0.30 | 0.34 | 0.42 | 0.37 | |
Capex/Depreciation |
(1.67) | (1.82) | (1.22) | (1.37) | |
Revenue per Share |
1.65 | 1.71 | 7.11 | 6.43 | |
Operating CF per Share |
(0.88) | (1.03) | (4.97) | (4.64) | |
Capex per Share |
(0.11) | (0.14) | (0.44) | (0.47) | |
Capex to Sales |
0.07 | 0.08 | 0.06 | 0.07 |
Columns are period end dates · fundamentals updated 6 Nov 2026